bone metastases

Cabozantinib more effective than everolimus for treatment of kidney cancer bone metastases

By Sharon Kell|2018-01-16T09:10:23+00:0016 Jan 2018|Drug treatments|

Cabozantinib (Cabometyx) was more effective than everolimus (Afinitor) in people [...]

Comments Off

Management of bone metastases in renal cell carcinoma

By Sharon Kell|2017-12-18T12:37:14+00:0018 Dec 2017|Drug treatments|

The following video from Practise Update is an interview with [...]

Comments Off

Risk factors for bone metastases from renal cell carcinoma

By Sharon Kell|2017-11-20T09:55:08+00:0020 Nov 2017|Uncategorized|

Data from 372 people with renal cell carcinoma (RCC) were [...]

Comments Off

Cabozantinib recommended by NICE for second-line treatment of advanced kidney cancer

By Sharon Kell|2017-07-10T09:22:57+00:0010 Jul 2017|Drug treatments|

Today, the National Institute for Health and Care Excellence (NICE), [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org